FDA Drug Recalls

Recalls / Class III

Class IIID-0072-2022

Product

ZEE+ painaid ESF Extra-Strength Formula (Acetaminophen 250 mg, Aspirin 250 mg (NSAID), Caffeine 65 mg) tablets, 2 Tablets per/package, Packaged in a) 50-count packages/carton, b) 125-count packages/carton, PA-ESF 1414Z, Dist. by: Zee Medical Distributors, LLC Mason, OH 45040 (Shipping Label)

Affected lot / code info
Lot #: AK-9547, exp. date 22- Apr; AK-9941, exp. date 22-Dec

Why it was recalled

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Recalling firm

Firm
Ultra Seal Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
521 Main St, N/A, New Paltz, New York 12561-1609

Distribution

Quantity
1,968,150 tablets
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2021-10-13
FDA classified
2021-10-26
Posted by FDA
2021-11-03
Terminated
2022-03-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0072-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.